Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1997018232) PEPTIDES DERIVED FROM THE ONCOGENE PROTEINE BCR-ABL EXPRESSED BY LEUKEMIC CELLS AND UTILISATION THEREOF FOR THE THERAPY OF HUMAN LEUKEMIAE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1997/018232 International Application No.: PCT/FR1996/001799
Publication Date: 22.05.1997 International Filing Date: 14.11.1996
Chapter 2 Demand Filed: 12.06.1997
IPC:
A61K 38/00 (2006.01) ,A61K 48/00 (2006.01) ,C07K 14/47 (2006.01) ,C07K 14/82 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
48
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
46
from vertebrates
47
from mammals
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
82
Translation products from oncogenes
Applicants:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) [FR/FR]; 101, rue de Tolbiac F-75013 Paris, FR (AllExceptUS)
INSTITUT PASTEUR [FR/FR]; 28, rue du Docteur-Roux F-75724 Paris Cédex 15, FR (AllExceptUS)
LANGLADE-DEMOYEN, Pierre [FR/FR]; FR (UsOnly)
ABASTADO, Jean-Pierre [FR/FR]; FR (UsOnly)
KOURILSKY, Philippe [FR/FR]; FR (UsOnly)
Inventors:
LANGLADE-DEMOYEN, Pierre; FR
ABASTADO, Jean-Pierre; FR
KOURILSKY, Philippe; FR
Agent:
LE GUEN, Gérard; Cabinet Lavoix 2, place d'Estienne-d'Orves F-75441 Paris Cédex 09, FR
Priority Data:
95/1361016.11.1995FR
Title (EN) PEPTIDES DERIVED FROM THE ONCOGENE PROTEINE BCR-ABL EXPRESSED BY LEUKEMIC CELLS AND UTILISATION THEREOF FOR THE THERAPY OF HUMAN LEUKEMIAE
(FR) PEPTIDES DERIVES DE LA PROTEINE ONCOGENE BCR-ABL EXPRIMES PAR DES CELLULES LEUCEMIQUES ET LEUR UTILISATION POUR LA THERAPIE DES LEUCEMIES HUMAINES
Abstract:
(EN) The invention relates to peptides capable of inducing a response of human cytotoxic T lymphocytes (CTL) specifically directed against cells expressing the fusion protein BCR-ABL.
(FR) Cette invention a pour objet des peptides capables d'induire une réponse de lymphocytes T cytotoxiques (CTL) humains spécifiquement dirigée contre des cellules exprimant la protéine de fusion BCR-ABL.
Designated States: CA, JP, US
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: French (FR)
Filing Language: French (FR)